METHODS AND PROCESSES FOR ASSESSMENT OF GENETIC MOSAICISM

    公开(公告)号:US20200087710A1

    公开(公告)日:2020-03-19

    申请号:US16494500

    申请日:2018-03-19

    Applicant: SEQUENOM, INC.

    Abstract: Technology provided herein relates in part to non-invasive classification of one or more mosaic copy number variations (CNVs) for a test sample. Technology provided herein is useful for classifying a mosaic CNV for a sample as part of non-invasive pre-natal (NIPT) testing and oncology testing, for example. In particular, a method is provided for classifying presence or absence of genetic mosaicism for a biological sample, the method includes identifying a genetic copy number variation region in sample nucleic acid from a subject, e.g. a pregnant female, determining a fraction of nucleic acid having the copy number variation in the sample nucleic acid, determining a fraction of a minority nucleic acid, e.g. fetal nucleic acid, in the sample nucleic acid, comparing the two fractions to generate a mosaicism ratio, and classifying a presence or absence of a genetic mosaicism for the copy number variation region according to the mosaicism ratio.

    APPLICATION OF MOSAICISM RATIO IN MULTIFETAL GESTATIONS AND PERSONALIZED RISK ASSESSMENT

    公开(公告)号:US20240395357A1

    公开(公告)日:2024-11-28

    申请号:US17773671

    申请日:2020-11-02

    Applicant: SEQUENOM, INC.

    Abstract: Provided herein are bioinformatic tools and processes used to classify the presence or absence of genetic mosaicism for a copy number variation in one or more fetuses (e.g., predict whether one fetus or more than one fetus is affected with the copy number variation). Sample nucleic acid is subjected to a sequencing process and the resulting sequence reads are analyzed to identify a genetic copy number variation region. A genetic mosaicism for the copy number variation region is classified for one fetus or more than one fetus based on: (i) a mosaicism ratio of a fraction of nucleic acid having the copy number variation region to a fraction of fetal nucleic acid, and (ii) the chromosome having the genetic copy number variation region (e.g., the type of aneuploidy identified) or (ii) a number of fetuses being carried by the pregnant female.

Patent Agency Ranking